U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644130) titled 'Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive Disorder' on May 25.
Brief Summary: The aim of this study is to expand access to Bergen Four-Day Treatment (B4DT) in Finland and to integrate it into psychiatric care pathways at Tampere University Hospital (TAYS). A Bergen team has been established within TAYS Psychiatry and has been trained in collaboration with the B4DT team from HUS and the Norwegian developers. The objective of this study is to enhance understanding of the model's adaptability to the Finnish healthcare system, evaluate healthcare professionals' attitudes toward the intervention, and assess treatment outc...